Novartis' use of promotional materials making quality-of-life (QOL) claims for the antiparkinsonian agent entacapone [`Comtan']

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.335, 2001-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Limited attention is paid to health-related quality-of-life (QOL) issues

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 305, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

It is feasible to derive `an effective and reproducible utility measure from information collected from use of a QoL [quality of life] questionnaire'

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 326, 2001-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Towards More Consistent Use of Generic Quality-of-Life Instruments

By Neyt Mattias  

PharmacoEconomics, Vol. 28, Iss. 4, 2010-04 ,pp. : 345-346

Adis International

Access to resources Recommend Favorite

Developing Health-Related Quality-of-Life Instruments for Use in Asia: The Issues

By Yin Bun Cheung   Thumboo Julian  

PharmacoEconomics, Vol. 24, Iss. 7, 2006-01 ,pp. : 643-650

Adis International

Access to resources Recommend Favorite

Measuring quality of life (QOL) in paediatric patients is a challenge

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 250, 2000-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite